Latest Breaking News On - Oligoprogressive lesions - Page 1 : comparemela.com

Administration of stereotactic ablative body radiotherapy to oligoprogressive lesions delayed a change in systemic therapy in patients with estrogen receptor–positive/HER2-negative breast cancer enrolled to the prospective phase 2 AVATAR trial.

Palbociclib ibranceSteven davidPeter maccallum cancer centreBreast cancerStereotactic ablative body radiotherapyOligoprogressive lesionsEr positive breast cancerAvatar trialAstro annual meeting